With demand remaining strong across pharmacies, clinics, and healthcare providers, buyers should continue watching pricing trends and availability throughout the year.
Figure 1 Table 1 Historical discoveries in pregnene series neurosteroids
not approved Tirzepatide (Zepbound) Approved (Zepbound, Mounjaro) Semaglutide alone (Wegovy) Approved (Wegovy, Ozempic) Cagrilintide alone Investigational Feature Head-to-head data CagriSema Did not meet non-inferiority vs tirzepatide at 84 wks (Reuters Feb 2026) Tirzepatide (Zepbound) Semaglutide alone (Wegovy) Cagrilintide alone These compounds are not interchangeable
Health and safety risks Using unregulated or compounded peptides carries potential risks, including contamination, dosing inaccuracies, and unknown long-term effects
doi:10.1007/s00345-018-2494-1
The dose differs when you compare oral supplements with injections